Jean‐Michel Métreau

1.7k total citations
31 papers, 1.3k citations indexed

About

Jean‐Michel Métreau is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jean‐Michel Métreau has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 11 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Jean‐Michel Métreau's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers) and Liver Disease and Transplantation (6 papers). Jean‐Michel Métreau is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (7 papers) and Liver Disease and Transplantation (6 papers). Jean‐Michel Métreau collaborates with scholars based in France, Tunisia and Philippines. Jean‐Michel Métreau's co-authors include Daniel Dhumeaux, Elie‐Serge Zafrani, Françoise Roudot‐Thoraval, Pauline Jouët, Didier Mathieu, Daniel Cherqui, P. Berthelot, Hatem Boulahdour, Alain Rahmouni and Frédéric Charlotte and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Jean‐Michel Métreau

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Michel Métreau France 17 900 714 420 151 118 31 1.3k
R Chapman United Kingdom 17 586 0.7× 432 0.6× 549 1.3× 243 1.6× 83 0.7× 30 1.1k
R. Poupon France 16 1.4k 1.6× 1.3k 1.8× 641 1.5× 133 0.9× 256 2.2× 39 1.9k
H Popper United States 16 869 1.0× 941 1.3× 220 0.5× 69 0.5× 113 1.0× 55 1.5k
Linda Scully Canada 17 1.0k 1.1× 906 1.3× 308 0.7× 104 0.7× 107 0.9× 29 1.3k
J P Benhamou France 21 701 0.8× 491 0.7× 477 1.1× 90 0.6× 164 1.4× 61 1.4k
S Iwatsuki United States 20 735 0.8× 426 0.6× 743 1.8× 163 1.1× 229 1.9× 47 1.3k
R Brenard Belgium 17 526 0.6× 437 0.6× 215 0.5× 58 0.4× 167 1.4× 54 917
R. Poupon France 16 934 1.0× 946 1.3× 226 0.5× 68 0.5× 163 1.4× 52 1.3k
Giovanni Battista Gasbarrini Italy 16 445 0.5× 412 0.6× 430 1.0× 69 0.5× 73 0.6× 41 1.1k
Etsuko Hashimoto Japan 21 1.8k 2.0× 1.6k 2.3× 422 1.0× 130 0.9× 59 0.5× 55 2.3k

Countries citing papers authored by Jean‐Michel Métreau

Since Specialization
Citations

This map shows the geographic impact of Jean‐Michel Métreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Métreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Métreau more than expected).

Fields of papers citing papers by Jean‐Michel Métreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Michel Métreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Métreau. The network helps show where Jean‐Michel Métreau may publish in the future.

Co-authorship network of co-authors of Jean‐Michel Métreau

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Michel Métreau. A scholar is included among the top collaborators of Jean‐Michel Métreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Michel Métreau. Jean‐Michel Métreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allory, Yves, Jean‐Michel Métreau, & Elie‐Serge Zafrani. (2000). [Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease].. PubMed. 20(1). 52–5. 10 indexed citations
2.
Duvoux, Christophe, Daniel Cherqui, Vincent Di Martino, et al.. (1997). Nicardipine As Antihypertensive Therapy in Liver Transplant Recipients: Results of Long–Term Use. Hepatology. 25(2). 430–433. 6 indexed citations
3.
Mallat, Ariane, et al.. (1997). Case Report: Terbinafine-Induced Prolonged Cholestasis with Reduction of Interlobular Bile Ducts. Digestive Diseases and Sciences. 42(7). 1486–1488. 34 indexed citations
4.
Ziol, Marianne, Jeanne Tran Van Nhieu, Françoise Roudot‐Thoraval, et al.. (1996). A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C. Journal of Hepatology. 25(6). 833–841. 25 indexed citations
5.
Pawlotsky, Jean–Michel, F Roudot-Thoraval, Françoise Darthuy, et al.. (1996). Factors Affecting Treatment Responses to Interferon-  in Chronic Hepatitis C. The Journal of Infectious Diseases. 174(1). 1–7. 85 indexed citations
6.
Jouët, Pauline, Françoise Roudot‐Thoraval, Daniel Dhumeaux, & Jean‐Michel Métreau. (1994). Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology. 106(3). 686–690. 147 indexed citations
7.
Mavier, Philippe, et al.. (1993). [Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases].. PubMed. 17(12). 959–62. 34 indexed citations
9.
Pawlotsky, Jean–Michel, Lionel Deforges, Stéphane Bretagne, et al.. (1993). Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis.. Gut. 34(2 Suppl). S66–S68. 18 indexed citations
10.
Pawlotsky, Jean–Michel, Chantal André, Jean‐Michel Métreau, et al.. (1992). Multiple Nuclear Dots Antinuclear Antibodies Are Not Specific for Primary Biliary Cirrhosis. Hepatology. 16(1). 127–131. 19 indexed citations
11.
Genève, Jean, et al.. (1990). Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis. Journal of Hepatology. 11(2). 196–199. 5 indexed citations
12.
Zafrani, Élie Serge, Jean‐Michel Métreau, Catherine Douvin, et al.. (1990). Idiopathic biliary ductopenia in adults: A report of five cases. Gastroenterology. 99(6). 1823–1828. 24 indexed citations
13.
Delchier, Jean‐Charles, et al.. (1986). The Usefulness of Microscopic Bile Examination in Patients With Suspected Microlithiasis: A Prospective Evaluation. Hepatology. 6(1). 118–122. 41 indexed citations
14.
Métreau, Jean‐Michel, et al.. (1985). Ascitic fluid pH in alcoholic cirrhosis: a reevaluation of its use in the diagnosis of spontaneous bacterial peritonitis.. Gut. 26(4). 332–335. 31 indexed citations
15.
Girardin, Marc, et al.. (1985). Computer-aided selection of diagnostic tests in jaundiced patients.. Gut. 26(9). 961–967. 12 indexed citations
16.
Defrance, Rémy, et al.. (1982). [Active chronic hepatitis with incomplete CREST syndrome: value of anticentromere antibodies].. PubMed. 6(11). 949–50. 6 indexed citations
17.
Duvaldestin, P., et al.. (1980). Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones.. Gut. 21(8). 650–655. 33 indexed citations
18.
Delchier, J.C., Jean‐Michel Métreau, Vincent Lévy, P Opolon, & Daniel Dhumeaux. (1979). [Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)].. PubMed. 8(37). 2955–8. 1 indexed citations
19.
Lockhart, A, et al.. (1979). A computer-aided system for the diagnosis of hepato-biliary diseases. A comparison with the performance of physicians. Medical Informatics. 4(1). 35–42. 13 indexed citations
20.
Métreau, Jean‐Michel, J Yvart, Daniel Dhumeaux, & P. Berthelot. (1978). Role of bilirubin overproduction in revealing Gilbert's syndrome: is dyserythropoiesis an important factor?. Gut. 19(9). 838–843. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026